期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Emerging role of natural bioactive compounds in navigating the future of liver disease
1
作者 Neha Chaudhary Muhammad Arif +2 位作者 Sheeba Shafi Shom Prakash Kushwaha pushpendra soni 《iLIVER》 2025年第1期4-14,共11页
Liver diseases,including liver inflammation,fatty liver disease,cirrhosis,and hepatocellular carcinoma,represent significant global health challenges.Traditional treatments often emphasize symptom management,leading t... Liver diseases,including liver inflammation,fatty liver disease,cirrhosis,and hepatocellular carcinoma,represent significant global health challenges.Traditional treatments often emphasize symptom management,leading to increased interest in natural bioactive compounds for their potential therapeutic benefits.This review examines the role of natural bioactive compounds in managing hepatic disorders,with a particular focus on their mechanisms of action and supporting clinical evidence.Compounds such as curcumin,silymarin,resveratrol,triterpenoids,apigenin,and delphinidin derivatives have demonstrated promising hepatoprotective effects in preclinical studies,largely due to their anti-inflammatory,antioxidant,and anti-fibrotic properties.Nevertheless,further research is necessary to determine optimal dosing,safety profiles,and long-term effects.Understanding the mechanisms of action and therapeutic potential of these bioactive compounds may provide critical insights into their role in the treatment of hepatic diseases. 展开更多
关键词 Alcohol-associated hepatic disease Medicine-induced hepatic injury RESVERATROL Autoimmune hepatitis HEPATOPROTECTIVE Viral hepatitis Nonalcoholic fatty hepatic disease
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部